Intraday Price Movement and Volatility
On 11 Dec 2025, Tejnaksh Healthcare’s stock recorded an intraday low of Rs.14.01, representing a decline of 12.16% from the previous close. This drop followed two consecutive days of gains, signalling a reversal in short-term momentum. The stock’s intraday volatility was notably high at 6.6%, calculated from the weighted average price, underscoring the unsettled trading conditions. Additionally, the share price underperformed its sector by 11.8% on the day, highlighting relative weakness within the healthcare services segment.
Tejnaksh Healthcare is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a sustained downward trend over multiple time horizons, which may influence market sentiment and trading strategies.
Market Context and Comparative Performance
While Tejnaksh Healthcare’s stock has faced headwinds, the broader market environment has shown resilience. The Sensex opened flat but gained 65.48 points to trade at 84,437.45, a 0.05% increase. The benchmark index remains within 2.04% of its 52-week high of 86,159.02 and is supported by bullish moving averages, with the 50-day moving average positioned above the 200-day average. Mid-cap stocks led the market advance, with the BSE Mid Cap index rising by 0.11% on the same day.
In contrast, Tejnaksh Healthcare’s one-year stock performance stands at -37.09%, significantly lagging the Sensex’s 3.63% gain over the same period. This divergence emphasises the company’s relative underperformance within the healthcare services sector and the broader market.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Financial Performance and Valuation Metrics
Tejnaksh Healthcare’s financial data over recent years reveals subdued growth and profitability. The company’s net sales have shown a compound annual growth rate (CAGR) of -1.19% over the last five years, indicating a contraction in revenue generation. Return on Equity (ROE) averaged 9.52%, reflecting modest returns on shareholders’ funds. More recently, the ROE stood at 6.3%, accompanied by a price-to-book value ratio of 1.2, suggesting a valuation that is relatively attractive compared to peers.
Profitability trends have also been under pressure, with profits declining by 25.7% over the past year. Operating cash flow for the fiscal year was reported at Rs.0.38 crore, marking a low point in cash generation from core activities. These financial indicators contribute to the stock’s subdued market performance and valuation levels.
Historical Underperformance and Shareholder Structure
Tejnaksh Healthcare has consistently underperformed the BSE500 index over the last three annual periods, with the stock generating negative returns in each of those years. The one-year return of -37.09% further underscores the challenges faced by the company in regaining investor confidence and market traction.
The majority shareholding is held by promoters, which remains a key aspect of the company’s ownership structure. This concentration of ownership may influence strategic decisions and long-term planning.
Considering Tejnaksh Healthcare ? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Summary of Key Price Levels and Market Indicators
The stock’s 52-week high was Rs.29.50, reached earlier in the year, placing the current price of Rs.14.01 at less than half that peak level. This wide gap highlights the extent of the stock’s decline over the past year. The Sensex, by comparison, remains close to its own 52-week high, emphasising the relative weakness of Tejnaksh Healthcare’s share price movement.
Trading volumes and volatility have been elevated, reflecting active repositioning by market participants. The stock’s position below all major moving averages further signals a cautious outlook from a technical perspective.
Sector and Industry Context
Within the healthcare services sector, Tejnaksh Healthcare’s performance contrasts with broader sector trends. While the sector has seen pockets of strength, the company’s financial and market metrics indicate ongoing pressures. The stock’s valuation discount relative to peers suggests that the market is pricing in these challenges.
Overall, the stock’s movement to a new 52-week low of Rs.14.01 reflects a combination of subdued financial results, valuation considerations, and market dynamics within the healthcare services industry.
Only for Rs. 14,999 - Get Access to 2 Years + 6 Months of All Premium Features on MarketsMojo. As low as ₹500/month! Claim 83% OFF →
